window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women in Pharma

  • Digital & Data,Drug Discovery & Development,Opinion & Events

    AI governance in pharmacovigilance: Marie Flanagan calls for safety-specific frameworks to safeguard patient risk

    The integration of artificial intelligence into pharmacovigilance is prompting a [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 5, 2026
  • Opinion & Events

    Following your passions – even if your dream job doesn’t exist yet

    From a eureka moment at university to optimising clinical trial development through the applications of new technology at Coronado Research, Dr Jennifer Bradford’s career has combined her passions for healthcare, science and computing.

    May 5, 2026
  • Biotech & Pharma Business

    New independent pharma news platform, Discover Pharma, launches

    May 5, 2026
  • Opinion & Events

    Oxolife CEO wins EU Women Innovators Prize for work in fertility biotech

    May 5, 2026
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Spot Biosystems reports early clinical evidence for non-viral dystrophin delivery in Duchenne muscular dystrophy
    Categories: Advanced Therapies, Drug Discovery & Development
  • Neurizon strengthens manufacturing base with Elanco supply deal for ALS asset
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain
  • OrganaBio expands European access to perinatal and blood-derived research materials through Bio-Connect partnership
    Categories: Advanced Therapies, Biotech & Pharma Business
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top